An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection

Archives of Neurology

Volumn 64, Issue 1, 2007, Pages 97-102

  Sevigny, Jeffrey J ^a,f   Albert, Steven M ^a   McDermott, Michael P ^b   Schifitto, Giovanni ^b   McArthur, Justin C ^c   Sacktor, Ned ^c   Conant, Katherine ^c   Selnes, Ola A ^c   Stern, Yaakov ^a   McClernon, Daniel R ^d   Palumbo, Donna ^b   Kieburtz, Karl ^b   Riggs, Garrett ^b   Cohen, Bruce ^e   Marder, Karen ^a   Epstein, Leon G ^e  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GLAXOSMITHKLINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GELATINASE A; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; TIME OF DEATH;

ADULT; CD4 LYMPHOCYTE COUNT; CHEMOKINE CCL2; COHORT STUDIES; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; MORBIDITY; PROPORTIONAL HAZARDS MODELS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846113024     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.1.97     Document Type: Article

References (29)

1. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126:946-954.
2. Palella FJ Jr, Delaney KM, Moorman AC, et al; HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
3. Tarwater PM, Gallant JE, Mellors JW, et al. Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users. AIDS. 2004;18:2419-2423.
4. Mildvan D, Spritzler J, Grossberg SE, et al. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection. Clin Infect Dis. 2005;40:853-858.
5. 2-microglobulin and neopterin. J Infect Dis. 1996;174:294-298.
6. + T-cell counts. Eur J Clin Microbiol Infect Dis. 2001;20:253-259.
7. Sevigny JJ, Albert SM, McDermott MP, et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology. 2004;63:2084-2090.
8. Ellis RJ, Deutsch R, Heaton RK, et al; San Diego HIV Neurobehavioral Research Center Group. Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch Neurol. 1997;54:416-424.
9. Mayeux R, Stern Y, Tang MX, et al. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology. 1993;43:176-182.
10. Wilkie FL, Goodkin K, Eisdorfer C, et al. Mild cognitive impairment and risk of mortality in HIV-1 infection. J Neuropsychiatry Clin Neurosci. 1998;10:125-132.
11. Sacktor NC, Bacellar H, Hoover DR, et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol. 1996;2:404-410.
12. McArthur JC, Hoover DR, Bacellar H, et al; Multicenter AIDS Cohort Study. Dementia in AIDS patients: incidence and risk factors. Neurology. 1993;43:2245-2252.
13. Concha M, Selnes OA, McArthur JC, et al. Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Int J Addict. 1995;30:823-841.
14. Selnes OA, Jacobson L, Machado AM, et al; Multicenter AIDS Cohort Study. Normative data for a brief neuropsychological screening battery. Percept Mot Skills. 1991;73:539-550.
15. Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology. 1996;47:1247-1253.
16. Detels R, Munoz A, McFarlane G, et al; Multicenter AIDS Cohort Study Investigators. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA. 1998;280:1497-1503.
17. Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS. 1999;13:1933-1942.
18. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001;56:257-260.
19. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 1999;13:1249-1253.
20. Tozzi V, Balestra P, Galgani S, et al. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS. 1999;13:1889-1897.
21. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Soc Sci Med. 2000;50:1599-1605.
22. + adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944-1950.
23. Andrade AS, McGruder HF, Wu AW, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis. 2005;41:875-882.
24. Galimberti D, Schoonenboom N, Scarpini E, Scheltens P. Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann Neurol. 2003;53:547-548.
25. Losy J, Zaremba J. Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke. 2001;32:2695-2696.
26. Cinque P, Vago L, Mengozzi M, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS. 1998;12:1327-1332.
27. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE. β-Chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol. 1998;44:831-835.
28. de Lemos JA, Morrow DA, Sabatine MS, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003;107:690-695.
29. Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology. 2004;62:957-962.